Belite Bio, Inc American Depositary Shares

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLTE and other ETFs, options, and stocks.

About BLTE

Belite Bio, Inc. is a biopharmaceutical company engaged in the research and development of drugs. Its focus is on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease.

CEO

Yue Hsin Lin

CEOYue Hsin Lin

Employees

Employees20

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2018

Founded2018

Employees

Employees20

BLTE Key Statistics

Market cap

1.29B

Market cap1.29B

Price-Earnings ratio

-34.79

Price-Earnings ratio-34.79

Dividend yield

—

Dividend yield—

Average volume

29.78K

Average volume29.78K

High today

$43.36

High today$43.36

Low today

$40.94

Low today$40.94

Open price

$41.05

Open price$41.05

Volume

57.08K

Volume57.08K

52 Week high

$48.60

52 Week high$48.60

52 Week low

$11.00

52 Week low$11.00

Belite Bio, Inc American Depositary Shares

Why Robinhood?

Belite Bio, Inc. is a biopharmaceutical company engaged in the research and development of drugs. Its focus is on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Show more

BLTE Key Statistics

Belite Bio, Inc. is a biopharmaceutical company engaged in the research and development of drugs. Its focus is on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease.